DLX6 and gastric cancer: The specific mechanism of its action involves DLX6-AS1 functioning as an endogenous cancer-promoting ceRNA that upregulates OCT1 by binding with miR-204-5p, which is downregulated in GC and inhibits tumor progression through various mechanisms.